Perrigo Company plc (NYSE:PRGO) Given Average Rating of “Reduce” by Analysts

Perrigo Company plc (NYSE:PRGO) has been assigned an average rating of “Reduce” from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, three have given a hold recommendation and one has issued a buy recommendation on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $20.3333.

A number of analysts have issued reports on PRGO shares. Canaccord Genuity Group decreased their target price on Perrigo from $40.00 to $20.00 and set a “buy” rating for the company in a research report on Thursday, November 6th. JPMorgan Chase & Co. lowered their price objective on Perrigo from $20.00 to $18.00 and set a “neutral” rating on the stock in a research note on Monday, December 15th. Zacks Research lowered shares of Perrigo from a “hold” rating to a “strong sell” rating in a research report on Friday, November 7th. Wall Street Zen downgraded shares of Perrigo from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Finally, Jefferies Financial Group dropped their price target on shares of Perrigo from $27.00 to $23.00 and set a “hold” rating on the stock in a research note on Monday, October 27th.

Insider Buying and Selling at Perrigo

In related news, Director Geoffrey M. Parker acquired 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The shares were bought at an average cost of $14.18 per share, for a total transaction of $106,350.00. Following the purchase, the director owned 17,375 shares in the company, valued at $246,377.50. This trade represents a 75.95% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Perrigo

A number of institutional investors and hedge funds have recently modified their holdings of the company. Norges Bank bought a new stake in Perrigo during the 2nd quarter worth approximately $36,755,000. Perpetual Ltd grew its position in shares of Perrigo by 64.2% during the 3rd quarter. Perpetual Ltd now owns 3,149,878 shares of the company’s stock valued at $70,148,000 after purchasing an additional 1,231,400 shares in the last quarter. Ion Asset Management Ltd. increased its holdings in shares of Perrigo by 34.7% in the second quarter. Ion Asset Management Ltd. now owns 3,817,621 shares of the company’s stock worth $102,007,000 after purchasing an additional 983,727 shares during the period. Goldman Sachs Group Inc. raised its position in shares of Perrigo by 126.6% in the first quarter. Goldman Sachs Group Inc. now owns 1,159,768 shares of the company’s stock worth $32,520,000 after buying an additional 647,982 shares in the last quarter. Finally, State Street Corp boosted its stake in Perrigo by 9.5% during the second quarter. State Street Corp now owns 7,340,323 shares of the company’s stock valued at $196,134,000 after buying an additional 637,678 shares during the period. 95.91% of the stock is owned by hedge funds and other institutional investors.

Perrigo Trading Up 2.6%

NYSE:PRGO opened at $15.08 on Friday. Perrigo has a 52 week low of $12.17 and a 52 week high of $30.93. The firm has a 50-day moving average price of $13.96 and a two-hundred day moving average price of $20.40. The firm has a market cap of $2.07 billion, a price-to-earnings ratio of -39.67 and a beta of 0.40. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.44 and a current ratio of 2.51.

Perrigo (NYSE:PRGO) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.75 by $0.05. Perrigo had a positive return on equity of 9.16% and a negative net margin of 1.21%.The business had revenue of $1.04 billion for the quarter, compared to analysts’ expectations of $1.10 billion. During the same quarter in the previous year, the firm earned $0.81 earnings per share. The business’s revenue was down 4.1% on a year-over-year basis. Perrigo has set its FY 2025 guidance at 2.700-2.80 EPS. On average, equities analysts expect that Perrigo will post 2.56 earnings per share for the current fiscal year.

Perrigo Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 16th. Stockholders of record on Friday, November 28th were issued a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a dividend yield of 7.7%. The ex-dividend date of this dividend was Friday, November 28th. Perrigo’s dividend payout ratio (DPR) is presently -305.26%.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.